|1.||Xia, Zhong-jun: 2 articles (03/2014 - 01/2013)|
|2.||Wang, Liang: 2 articles (03/2014 - 01/2013)|
|3.||Li, Zhi-ming: 1 article (09/2015)|
|4.||Huang, Jia-jia: 1 article (09/2015)|
|5.||Xia, Yi: 1 article (09/2015)|
|6.||Sun, Peng: 1 article (09/2015)|
|7.||Liu, Pan-pan: 1 article (09/2015)|
|8.||Jiang, Wen-qi: 1 article (09/2015)|
|9.||Wang, Yu: 1 article (09/2015)|
|10.||Zhang, Wen-wen: 1 article (09/2015)|
01/01/2015 - "A total of fifty-one cases with nasal natural killer/T-cell lymphoma receiving initial GELOX chemotherapy were enrolled in this study. "
03/01/2014 - "Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE/IIE extranodal natural killer/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up."
01/01/2015 - "Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma."
01/15/2013 - "First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma."
|2.||Extranodal NK-T-Cell Lymphoma
|2.||Drug Therapy (Chemotherapy)